Stille AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0000998650
SEK
189.50
0.5 (0.26%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Stille AB stock-summary
stock-summary
Stille AB
Pharmaceuticals & Biotechnology
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Company Coordinates stock-summary
Company Details
Ekbacken 11 , TORSHAELLA None : 644 30
stock-summary
Tel: 46 8 58858000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Goran Brorsson
Chairman of the Board
Mr. Tomas Anderzon
Director
Mr. Bengt Julander
Director
Ms. Sirpa Makipaa
Director, Employee Representative
Mr. Stefan Tell
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
125 Million
(Quarterly Results - Jun 2025)
Net Profit:
10 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 1,577 Million (Small Cap)

stock-summary
P/E

34.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.20

stock-summary
Return on Equity

5.91%

stock-summary
Price to Book

2.28